The exact numbers your care team is looking for — fasting, one hour after eating, two hours after eating — plus how those thresholds are set, how they are measured, and what to do when a reading lands outside the range.
In gestational diabetes, the American Diabetes Association's 2026 Standards of Care set treatment targets of fasting glucose below 95 mg/dL, one hour after a meal below 140 mg/dL, and two hours after a meal below 120 mg/dL.[1] Diagnosis itself uses a 75-g or 100-g oral glucose tolerance test, with abnormal thresholds ranging from 92 to 180 mg/dL depending on the test protocol and time point.
- What blood sugar levels mean in gestational diabetes
- The target numbers, time point by time point
- How gestational diabetes is diagnosed
- Why glucose rises in pregnancy: causes and risk factors
- Symptoms — and why there often aren't any
- How to check your levels correctly at home
- What happens when levels stay above target
- Bringing levels into range: food, movement, medication
- When to call your care team
- Frequently asked questions
What Blood Sugar Levels Mean in Gestational Diabetes
Gestational diabetes mellitus (GDM) is glucose intolerance that is first recognized during the second or third trimester of pregnancy, in someone who did not meet criteria for diabetes before conception. It is not the same condition as pre-existing type 1 or type 2 diabetes, and it is not a mild form of either — it is a distinct metabolic state created by pregnancy itself.
Roughly 1 in 10 pregnancies in the United States is affected each year, making GDM one of the most common medical complications of pregnancy.[2] That scale matters, because the blood sugar numbers attached to GDM are not abstract — they determine whether a pregnancy is managed with nutrition alone or with medication, how often fetal growth is monitored, and when delivery is planned.
The core problem is a mismatch. As the placenta grows, it releases hormones — human placental lactogen, progesterone, cortisol, placental growth hormone — that deliberately blunt insulin's ability to move glucose out of the bloodstream and into cells. This is normal and adaptive: it ensures the fetus gets a steady fuel supply. What is not normal is when the pancreas cannot scale up insulin output enough to overcome that resistance. Blood glucose then drifts upward, first after meals, later in the fasting state.
Fasting glucose is usually the last number to go abnormal — and the first one to signal that nutrition therapy alone is no longer holding.
Because the resistance rises progressively across pregnancy, GDM typically becomes detectable between 24 and 28 weeks, when placental hormone output peaks. It usually resolves within hours to days after delivery, once the placenta is removed — though the underlying metabolic vulnerability does not disappear, which is why postpartum testing matters.
The Target Numbers, Time Point by Time Point
Treatment targets in pregnancy are deliberately tighter than targets for type 2 diabetes outside of pregnancy. The reason is fetal: glucose crosses the placenta freely by facilitated diffusion, so maternal blood glucose is effectively the fetus's blood glucose. A maternal reading of 160 mg/dL after a meal produces a fetal exposure of similar magnitude, which drives fetal insulin production and excess growth.
The ADA's 2026 Standards of Care list the following capillary plasma-equivalent targets for pregnant people with GDM:[1]
| Time point | Target (mg/dL) | Target (mmol/L) | What it tells you |
|---|---|---|---|
| Fasting (on waking, before eating) | < 95 | < 5.3 | How well overnight insulin output is holding against placental resistance |
| 1 hour after the first bite of a meal | < 140 | < 7.8 | Peak post-meal excursion; most sensitive to meal composition |
| 2 hours after the first bite of a meal | < 120 | < 6.7 | How quickly glucose is clearing; reflects insulin response and activity |
| HbA1c (if used) | < 6% | — | Not reliable in pregnancy; used as a secondary check only |
Clinics typically ask for four checks a day: one fasting and one after each of three meals. Some teams alternate one-hour and two-hour post-meal testing depending on which protocol they use; you should follow whichever your practice specifies, and not switch between them mid-pregnancy, because the thresholds are not interchangeable.
The UK's NICE guideline NG3 uses a fasting target below 5.6 mmol/L (about 101 mg/dL), one hour after meals below 7.8 mmol/L (140 mg/dL), and two hours after meals below 6.4 mmol/L (about 115 mg/dL).[4] The differences are small but real — a fasting reading of 97 mg/dL is above the ADA target and below the NICE target. Use the numbers your own clinic gives you, and ask which guideline they follow if it is not stated.
One practical nuance: these targets are not a pass/fail exam where a single elevated value means failure. Most services look at patterns over one to two weeks. Consistently reaching 150 mg/dL at one hour after breakfast is actionable; one 148 mg/dL reading after a birthday dinner usually is not.
How Gestational Diabetes Is Diagnosed
Diagnostic thresholds are not the same as treatment targets, and mixing them up is one of the most common sources of confusion. Diagnosis uses a provoked test — a measured glucose load — rather than everyday readings.
Two testing strategies are in use, and both remain acceptable under current ADA and ACOG guidance.[1][3] The one-step approach is a 75-g oral glucose tolerance test performed fasting, with plasma glucose drawn at baseline, one hour, and two hours. The two-step approach starts with a non-fasting 50-g glucose challenge; if the one-hour value meets a screening cutoff, it is followed by a fasting 100-g, three-hour diagnostic test.
| Protocol | Glucose load | Thresholds (mg/dL) | Diagnosis requires |
|---|---|---|---|
| One-step (IADPSG/WHO-style) | 75 g | Fasting ≥ 92; 1 h ≥ 180; 2 h ≥ 153 | Any single value at or above threshold |
| Two-step, Carpenter–Coustan | 100 g | Fasting ≥ 95; 1 h ≥ 180; 2 h ≥ 155; 3 h ≥ 140 | Two or more values at or above threshold |
| Two-step, NDDG (older) | 100 g | Fasting ≥ 105; 1 h ≥ 190; 2 h ≥ 165; 3 h ≥ 145 | Two or more values at or above threshold |
The one-step test diagnoses more people — roughly two to three times as many as the two-step approach — because it requires only one abnormal value. That is a policy trade-off rather than a biological fact, and it is why different health systems land in different places. Neither approach has been shown to be clearly superior for long-term maternal or infant outcomes.
Standard screening happens at 24–28 weeks. The ADA recommends testing earlier — at the first prenatal visit — for people with obesity, prior GDM, a strong family history of type 2 diabetes, polycystic ovary syndrome, or previous delivery of a large-for-gestational-age infant.[1] An early normal result should still be repeated at 24–28 weeks, because insulin resistance climbs substantially in the interim.
Why Glucose Rises in Pregnancy: Causes and Risk Factors
Some risk is unavoidable biology; some is modifiable; some is simply genetic. Expand each item below for the mechanism and what it means practically.
Placental hormones that block insulin action
Human placental lactogen, placental growth hormone, progesterone, cortisol, and prolactin all rise steadily across pregnancy and all impair insulin signaling. This is the universal driver — every pregnancy involves it. GDM develops when beta-cell insulin output cannot rise far enough to compensate. The resistance typically peaks in the third trimester, which is why glucose control can deteriorate late even when earlier readings were normal.
Pre-pregnancy weight and weight gain trajectory
Obesity is the single strongest modifiable risk factor. Excess adipose tissue raises baseline insulin resistance before pregnancy even begins, meaning the pancreas starts from a deficit. Rapid gestational weight gain in the first half of pregnancy adds further risk. Importantly, gestational weight gain above or below Institute of Medicine guidance is associated with worse outcomes in both directions — too little gain carries its own risks, so restriction is not the answer.
Previous gestational diabetes or a large previous baby
A history of GDM raises recurrence risk substantially in a subsequent pregnancy, and it also predicts later type 2 diabetes. A prior infant weighing 9 pounds or more (macrosomia) suggests that an earlier pregnancy may have carried undiagnosed glucose intolerance. Both warrant early testing rather than waiting until 24–28 weeks.
Family history, ethnicity, and genetics
A first-degree relative with type 2 diabetes increases risk, and GDM risk is higher among people of South Asian, Hispanic, African American, Native American, Pacific Islander, and East Asian ancestry. These differences reflect a mix of genetic predisposition, body composition at a given BMI, and social determinants of health — not any inherent defect. They matter for screening decisions, not for blame.
PCOS and other metabolic conditions
Polycystic ovary syndrome, pre-pregnancy prediabetes, chronic hypertension, and dyslipidemia all cluster with insulin resistance and each independently raises GDM risk. If you have any of these, ask about early glucose testing at your first prenatal visit rather than assuming screening at 24–28 weeks is sufficient.
Age and pregnancy history
Risk rises with maternal age, with a meaningful step up after age 35. Higher parity also modestly increases risk. These are non-modifiable, which is precisely why they belong in a screening decision rather than a prevention plan.
Medications and sleep
Systemic corticosteroids — often given for fetal lung maturity or for other conditions — can push glucose sharply upward for several days. Some antipsychotics and immunosuppressants also affect glucose. Short sleep duration and untreated obstructive sleep apnea are increasingly recognized contributors to insulin resistance in pregnancy. Mention every medication and any snoring or witnessed apnea to your obstetric team.
Symptoms — and Why There Often Aren't Any
Most people with gestational diabetes feel completely well. That is the defining characteristic of the condition and the reason universal screening exists: GDM is usually silent, and a pregnancy that "feels fine" can still carry glucose levels high enough to drive fetal overgrowth.
When symptoms do appear, they mirror the classic hyperglycemia picture — excessive thirst, frequent urination (beyond normal pregnancy frequency), fatigue that feels different from ordinary pregnancy tiredness, blurred vision, recurrent yeast or urinary infections, and slow-healing minor wounds.[5] These are non-specific and overlap heavily with normal pregnancy complaints, which is another reason symptoms cannot substitute for a glucose test.
Clinicians sometimes pick up clues before a glucose test: fetal measurements tracking well above gestational age on ultrasound, excess amniotic fluid (polyhydramnios), or glucose detected on a routine urine dipstick. None of these confirm GDM, but any of them should prompt a glucose tolerance test regardless of where you are in the screening schedule.
How to Check Your Levels Correctly at Home
Home monitoring is only as useful as the technique behind it. The gap between a well-taken and a poorly-taken capillary sample can easily exceed 20 mg/dL — enough to trigger an unnecessary insulin prescription or to hide a genuine problem. Work through this list with your diabetes educator before you start testing alone.
Testing immediately after a walk or household chores can read lower than a true resting post-meal value. Squeezing the fingertip hard dilutes the sample with tissue fluid. Reusing a lancet blunts it and encourages squeezing. And testing at inconsistent times day to day makes week-to-week comparison nearly meaningless.
Well-managed GDM produces a fairly flat pattern: fasting values hovering in the 80s to low 90s mg/dL, post-meal peaks that rise and fall within an hour or two, and no single day dominating the two-week log. Occasional outliers are expected. A stable trend line, with no more than a small fraction of readings above target, is the goal.
What Happens When Levels Stay Above Target
Sustained maternal hyperglycemia drives fetal hyperglycemia, which drives fetal insulin production. Insulin is a growth hormone in the fetus, and the result is disproportionate fat deposition — particularly across the shoulders and trunk — even when overall head size is normal. That specific growth pattern is what makes delivery mechanically difficult.
| Outcome | Mechanism | Who it affects |
|---|---|---|
| Macrosomia (birth weight > 4,000–4,500 g) | Fetal hyperinsulinemia drives fat and protein synthesis | Infant |
| Shoulder dystocia and birth injury | Asymmetric growth with broad shoulders passing a tight pelvic outlet | Infant |
| Cesarean delivery | Larger estimated fetal weight and failed progress in labor | Both |
| Neonatal hypoglycemia | Abrupt loss of maternal glucose supply while infant insulin remains high | Infant |
| Pre-eclampsia | Shared metabolic and vascular dysfunction | Pregnant person |
| Polyhydramnios | Fetal osmotic diuresis increasing amniotic fluid | Both |
| Later type 2 diabetes | Underlying beta-cell vulnerability persists after delivery | Pregnant person |
The long-term picture deserves particular attention. Roughly half of people who have gestational diabetes go on to develop type 2 diabetes within 5 to 10 years.[2] That makes the postpartum period a genuine window for prevention rather than a formality — an oral glucose tolerance test at 4 to 12 weeks after delivery, then lifelong periodic screening, is the recommended follow-up.[1]
Two points of reassurance are worth stating plainly. First, the risk gradients are dose-dependent: mildly elevated numbers carry far less risk than consistently high ones, and most GDM managed with nutrition alone produces outcomes statistically indistinguishable from uncomplicated pregnancies. Second, the interventions work — treatment of GDM reduces the rate of macrosomia and shoulder dystocia compared with no treatment.
Bringing Levels Into Range: Food, Movement, Medication
Roughly 70–85% of people with gestational diabetes reach target glucose with nutrition therapy plus activity alone. The approach is not a strict elimination diet; it is a redistribution of carbohydrate across the day, paired with protein, fat, and fiber to flatten the post-meal curve.
Fasting glucose should be maintained below 95 mg/dL, with one-hour postprandial values below 140 mg/dL and two-hour postprandial values below 120 mg/dL. Insulin remains the preferred first-line pharmacologic agent for gestational diabetes because it does not cross the placenta to a clinically significant degree.
When to Call Your Care Team
Most out-of-range readings are managed at your next scheduled visit. The situations below are different — they warrant a same-day call rather than a note in your log.
Frequently Asked Questions
What is a normal fasting blood sugar in pregnancy without gestational diabetes?
Fasting glucose in an uncomplicated pregnancy typically sits between 70 and 92 mg/dL (3.9–5.1 mmol/L). Values at or above 92 mg/dL on a formal fasting test fall into the diagnostic range for gestational diabetes under the one-step protocol. Ordinary home readings taken during pregnancy that land in the low 90s are usually benign, but a consistent pattern there is worth mentioning to your clinician.
Should I test one hour or two hours after eating?
Follow whichever your clinic prescribes. The ADA targets are below 140 mg/dL at one hour or below 120 mg/dL at two hours — either is acceptable, but the numbers are not interchangeable. Testing at one hour captures the peak; testing at two hours captures clearance. If your clinic says "one hour," a two-hour reading of 118 mg/dL does not tell you whether you met the one-hour target.
Can gestational diabetes be managed without insulin?
Yes, for most people. Roughly 70–85% of cases reach target glucose with nutrition therapy and physical activity alone. The deciding factor is usually the fasting glucose: post-meal values often respond well to meal composition and walking, while fasting values reflect overnight hepatic glucose output and are less diet-responsive. If fasting readings stay at or above 95 mg/dL for one to two weeks despite appropriate nutrition, insulin is typically the next step.
What happens to my blood sugar after delivery?
Glucose usually normalizes within hours to days of delivery, because the placenta — the source of the insulin-blocking hormones — is gone. Insulin requirements drop sharply and immediately; anyone on insulin during pregnancy should expect a significant dose reduction or discontinuation. Despite that rapid normalization, an oral glucose tolerance test is recommended at 4 to 12 weeks postpartum, followed by lifelong periodic screening, because about half of people with GDM develop type 2 diabetes within 5 to 10 years.[2]
Does one high reading mean I've failed?
No. Glucose control is assessed as a pattern, not a single data point. A reading of 145 mg/dL at one hour that follows a restaurant meal, a poor night's sleep, or a mild illness is not a treatment failure. What clinicians act on is the proportion of readings above target over one to two weeks — typically, an escalation decision follows when a consistent 20–30% or more of readings at a given time point exceed the threshold.
Can I still eat fruit with gestational diabetes?
Yes. Whole fruit contains fiber and water that slow glucose absorption, and it is a reasonable carbohydrate source for most people with GDM. Portion and form matter much more than the fruit itself: a medium apple with nut butter behaves very differently from a glass of apple juice. Fruit taken alone on an empty stomach, particularly first thing in the morning, is more likely to spike glucose than fruit eaten as part of a mixed meal.
Are continuous glucose monitor readings the same as fingerstick readings?
Not exactly. Continuous glucose monitors measure interstitial fluid glucose, which lags behind blood glucose by roughly 5–15 minutes and is most divergent when glucose is changing rapidly — right after a meal, for example. The pregnancy targets above are validated for capillary blood glucose. The ADA notes that evidence for CGM use in gestational diabetes specifically is still limited, so a CGM should be used alongside, not instead of, the monitoring protocol your clinic prescribes.[1]
- ADA 2026 treatment targets in gestational diabetes are fasting below 95 mg/dL, one hour post-meal below 140 mg/dL, and two hours post-meal below 120 mg/dL.
- Diagnostic thresholds are different from treatment targets: the one-step 75-g test uses cutoffs of 92/180/153 mg/dL, while the two-step 100-g test uses 95/180/155/140 mg/dL and requires two abnormal values.
- Gestational diabetes is usually asymptomatic; universal screening at 24–28 weeks exists precisely because symptoms cannot be relied on.
- Roughly 70–85% of cases are controlled with nutrition therapy and post-meal walking; insulin is the preferred medication when targets are not met.
- Glucose normalizes within days of delivery, but about half of people with GDM develop type 2 diabetes within 5–10 years, making the 4–12 week postpartum glucose test essential.
- Home readings are only meaningful if technique is consistent — clean dry hands, timing from the first bite, and a log that pairs numbers with meals.
- American Diabetes Association. Standards of Care in Diabetes—2026: Section 2, Diagnosis and Classification of Diabetes; Section 15, Management of Diabetes in Pregnancy. diabetes.org
- Centers for Disease Control and Prevention. Gestational Diabetes and National Diabetes Statistics Report. cdc.gov
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 190: Gestational Diabetes Mellitus. acog.org
- National Institute for Health and Care Excellence (NICE). Diabetes in Pregnancy: Management From Preconception to the Postnatal Period (NG3). nice.org.uk
- National Institute of Diabetes and Digestive and Kidney Diseases. Gestational Diabetes. niddk.nih.gov
